Insulet (PODD) Convertible Debt (2010 - 2011)
Insulet posted quarterly Convertible Debt of $106.3 million for Q3 2011, up 2.06% on a QoQ basis from $104.2 million in Q2 2011.
Insulet (PODD) has 2 years of Convertible Debt data on file, last reported at $106.3 million in Q3 2011.
- For the quarter ending Q3 2011, Convertible Debt changed N/A year-over-year to $106.3 million; the trailing twelve-month figure through Sep 2011 stood at $106.3 million (changed N/A YoY), and the FY2010 full-year result was $69.4 million, changed N/A from the prior year.
- Convertible Debt for Q3 2011 stood at $106.3 million, up from $104.2 million in the prior quarter.
- Across five years, Convertible Debt topped out at $106.3 million in Q3 2011 and bottomed at $69.4 million in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 106.32 Mn |
| Jun 30, 2011 | 104.18 Mn |
| Dec 31, 2010 | 69.43 Mn |